The rising cost of healthcare is frightening. Anyone with a chronic or major medical health condition realizes just how much. Having a medical problem which requires prescription medications for long-term use or even the rest of your life could not only put a crimp in your lifestyle, but in many cases cost more than a brand new house.
Patients with chronic conditions like cancer, rheumatoid arthritis, MS (multiple sclerosis) and several other similar illnesses will soon find they will pay more for their medications. These are diseases where people discover every day they need one or more meds to live and they are very expensive. More than a few states have decided to make patients pay for the cost of their medications regardless of new federal healthcare legislation expected to help them out with the cost.
For instance, California will have patients pay at the very least 30 percent of the cost of most of the most expensive drugs patients in these categories of illness take. Other states in the nation are advising they will have patient’s pay flat copays. All of these changes are in response to the rolling out of the federal Affordable Care Act.
Anyone lucky enough or healthy enough not to need any of the pricey prescriptions which fall in the class of meds targeted by states for these changes, will have the money to buy a new house.
Anyone unlucky enough or sick and need these medicines to live everyday will have a choice of buying a house to live in or paying for medicine. These are 7 prescriptions which cost more than a new house.
Avastin is created by Genentech and used to treat a variety of cancers. It will decrease the amount of new blood vessels which has promised in helping cancer patient’s extend their lives by more than a couple of months. The cost is upwards of $100,000 each year.
Prescribed for rheumatoid arthritis, MS and Gaucher disease it costs around$200,000 each year. It is used for the removal of fatty buildups in the spleen, brain and heart. Genzyme is the manufacturer and makes it with hamster cells which are genetically engineered.
Costing at least $375,000 a year to treat Hunter’s Syndrome, Elaphrase is from Shire Human Genetics Company. It replaces a much-needed enzyme in patient’s afflicted with Hunter’s Syndrome. The disease is genetically focused exclusively to men with symptoms which cause mental and physical impairment.
The drug decreases the symptoms and helps patients with their ability to walk.
One of the newest on the market at $115,000 a month is Iclusing. Used to treat chronic myeloid leukemia and made by the company Ariad it is very expensive. It runs $115,000 a year. It has successfully treated those afflicted where other forms of treatment have failed.
This one treats multiple sclerosis and runs a patient a cool $55,000 every year. Biogen is the manufacturer and along with Tecfidera they have two other rxs for the same condition which are $60,000 and $45,000 every year. Although most expensive medications are found in liquid form, all three of these are oral medications.
Pfizer gained FDA approval last year for this one. Treating rheumatoid arthritis is a chronic lifetime job and at $25,000 every year, 6 years of this medicine is almost a quarter of a million dollars. According to Forbes magazine this is one of the cheaper medicines for treating RA.
This new to the market med treats colorectal cancers and is $11,000 a month for users. The Sloan Kettering Cancer Center has even refused to use it to treat patients because of the price. According to a New York Times article several doctors at the hospital there are more than several other medications already on the market which are less expensive and just as effective.
Anyone that doesn’t believe that healthcare costs are out of hand should check this listing of seven medications which will cost more than a house for patients to use. Nearly every one of the conditions being treated is chronic which means the yearly costs could run for decades. Who will pay for these and how are two questions to answer and certainly worth investigating.